Zobrazeno 1 - 10
of 108
pro vyhledávání: '"T. Habeshaw"'
Autor:
S. B. Kaye, A. N. Harnett, T. Habeshaw, Donald Bissett, Duncan I. Jodrell, M Williams, D Evans, Peter Canney
Publikováno v:
British Journal of Cancer
With the aim of increasing the dose intensity of chemotherapy in breast cancer, 14 patients with stage II-IV breast cancer were treated with FEC chemotherapy at 2 week intervals together with granulocyte colony-stimulating factor (G-CSF) 5 micrograms
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2cf2cf9fa208d9c7af1fe2e1385a50a
https://doi.org/10.1038/bjc.1995.247
https://doi.org/10.1038/bjc.1995.247
Autor:
M A Macham, M. Soukop, Donald Bissett, R C Leonard, James Paul, Gordon C. Wishart, A. N. Harnett, David J. Kerr, Duncan I. Jodrell, T. Habeshaw
Publikováno v:
Journal of Clinical Oncology. 12:1771-1777
PURPOSE To evaluate the effect of quinidine, a putative modulator of P-glycoprotein-mediated drug resistance, on the response rate and toxicity profile of epirubicin in patients with advanced breast cancer. PATIENTS AND METHODS Between 1989 and 1992,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e307a3cf1c9a860c65c7eb11d743e3c1
https://doi.org/10.1200/jco.1994.12.9.1771
https://doi.org/10.1200/jco.1994.12.9.1771
Autor:
T. Habeshaw, S.B. Pinion
Publikováno v:
International Journal of Gynecological Cancer. 2:332-335
Sixty-three patients under the age of 50 years who were long-term survivors following radiotherapy for cervical cancer and had been placed on hormone replacement therapy (HRT) were identified. The median age at treatment was 37 years and the mean del
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab54c55ac6ef47cd31561404cf16cf09
https://doi.org/10.1046/j.1525-1438.1992.02060332.x
https://doi.org/10.1046/j.1525-1438.1992.02060332.x
Publikováno v:
Clinical Oncology. 2:193-198
Between 1982 and 1985, 240 patients with carcinoma of cervix were treated by radical radiotherapy, 140 using the selectron at the Royal Beatson Memorial Hospital (RBMH) and 100 with conventional caesium at the Western Infirmary. To allow for the incr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69b0ca8fbf95e3a9b4668e82aca7d925
https://doi.org/10.1016/s0936-6555(05)80167-0
https://doi.org/10.1016/s0936-6555(05)80167-0
Autor:
Martin Gore, Christian Rothermundt, C. Keyzor, T Ahmad, I Gibbens, R. Hubner, T Habeshaw, Stan B. Kaye
Publikováno v:
British Journal of Cancer
Platinum-based combination chemotherapy has been proven to be superior to single-agent platinum in the treatment of relapsed ovarian cancer after a treatment-free interval of more than 6 months. A response rate of 41% was previously reported by our g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff0d993487b220a19414adf7899a4f27
https://pubmed.ncbi.nlm.nih.gov/16306873
https://pubmed.ncbi.nlm.nih.gov/16306873
Publikováno v:
International journal of clinical practice. 58(6)
Trastuzumab is a humanised monoclonal antibody against the extracellular domain of HER2 (human epidermal growth factor receptor-2) that is overexpressed in about 25% of human breast cancers. It has shown clinical benefit in HER2-positive breast cance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5dabfbe09180310d84279b22d30b85f4
https://pubmed.ncbi.nlm.nih.gov/15311558
https://pubmed.ncbi.nlm.nih.gov/15311558
Publikováno v:
Clinical oncology (Royal College of Radiologists (Great Britain)). 12(6)
We report three patients in whom standard radiation therapy was given and serious late radiation damage was seen. The first patient suffered recurrent parotiditis and a parotid fistula. He was treated initially with 20 Gy in ten fractions via a 300 k
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::395bb7ec1d91b7ab3ebec6c64b28fe02
https://pubmed.ncbi.nlm.nih.gov/11202094
https://pubmed.ncbi.nlm.nih.gov/11202094
Autor:
T. Habeshaw, A. Stewart, R. Hunter, Susan E Davidson, J. Davis, H. Yosef, T. K. Sarkar, N.S. Reed, R.P. Symonds, E. Pyper, V.J. Cowie, James Paul
Publikováno v:
European journal of cancer (Oxford, England : 1990). 36(8)
204 eligible patients were entered into a multicentre randomised trial of neo-adjuvant chemotherapy prior to radical radiotherapy. The aim of this study was to assess whether there was any survival advantage in patients undergoing chemotherapy and ra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12489ad3eeb7eae4c012b1f864d14bb3
https://pubmed.ncbi.nlm.nih.gov/10885603
https://pubmed.ncbi.nlm.nih.gov/10885603
Autor:
Melanie Mackean, Duncan I. Jodrell, James Paul, A.G. Robertson, A. McInnes, N. S. Reed, T. Habeshaw, J. Cassidy, Peter Canney, Chris Twelves, H. Yosef
Publikováno v:
British Journal of Cancer
We have used a relatively new trial methodology, the group sequential design, to prospectively evaluate two dose levels of bolus/infusional 5-fluorouracil (5-FU) and folinic acid in 192 consecutive-patients with advanced colorectal carcinoma. On day
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::501e739d5e9311eeef72e53f36fc1acc
https://pubmed.ncbi.nlm.nih.gov/9652765
https://pubmed.ncbi.nlm.nih.gov/9652765
Publikováno v:
Cancer chemotherapy and pharmacology. 41(2)
Our previous randomised trial in patients with advanced ovarian cancer indicated a significant response and survival advantage for those receiving high-dose (100 mg/m2) as compared with low-dose (50 mg/m2) cisplatin in combination with cyclophosphami
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fc00ab678dee91a15c67ab903bc0e28
https://pubmed.ncbi.nlm.nih.gov/9443630
https://pubmed.ncbi.nlm.nih.gov/9443630